Our March, 2020 Quick Question, "How does your facility measure extended half-life factor VIII concentrate therapy?" drew 24 votes, reflecting the number of laboratories serving Hemophilia and Bleeding Disorders services worldwide. Here are the answers:
Posts - Bleeding Disorders
Mar 31, 2020 1:18pm
0 Comments
Mar 23, 2020 2:02pm
Today, March 23, 2020, the International Journal of Laboratory Hematology released a study describing the clinical efficacy attributes of PTT-based one-stage clotting assays and two-stage chromogenic assays for the extended half-life factor IX concentrate, Alprolix. Click or tap the citation for the open-access article. Thank you to Dr.
0 Comments
Mar 23, 2020 9:50am
Here is a JTH free-access brief report that illustrates mortality-related DIC
parameters in coronavirus pneumonia, hinting at
potential interventional therapy.
0 Comments
Mar 11, 2020 9:44am
An acquaintance's daughter has type 1 von Willebrand disease. Her OB physician recommends a daily baby aspirin during her pregancy. Are there any circumstances in which aspirin is indicated during pregnancy in a woman with VWD
0 Comments
